Watch for Cabenuva, a New Monthly Injectable for HIV

Cabenuva (cabotegravir/rilpivirine) will be the first MONTHLY injectable treatment for adults living with HIV.

Cabenuva comes in a kit containing one vial of cabotegravir and one vial of rilpivirine. For a dose, each med is injected into the buttock (gluteal) muscle by a clinician.

Be aware that it's a specialty med that costs about $4,000/month.

Get unlimited access through an Enterprise license

Hospital Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals